429 related articles for article (PubMed ID: 15308367)
21. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
[TBL] [Abstract][Full Text] [Related]
22. Measles-rubella mass immunization campaign in Albania, November 2000.
Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of three different vaccination strategies against measles in Zambian children.
Dayan GH; Cairns L; Sangrujee N; Mtonga A; Nguyen V; Strebel P
Vaccine; 2004 Jan; 22(3-4):475-84. PubMed ID: 14670330
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of vaccination policies. The case of measles].
Lafarge H; Levy E; Rey M
Rev Epidemiol Sante Publique; 1985; 33(3):182-93. PubMed ID: 4081224
[TBL] [Abstract][Full Text] [Related]
25. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
Yaméogo KR; Yaméogo A; Nacoulma SD; Zuber PL
J Infect Dis; 2003 May; 187 Suppl 1():S74-9. PubMed ID: 12721895
[TBL] [Abstract][Full Text] [Related]
26. Mass measles vaccination in urban Burkina Faso, 1998.
Zuber PL; Conombo KS; Traoré AD; Millogo JD; Ouattara A; Ouédraogo IB; Valian A
Bull World Health Organ; 2001; 79(4):296-300. PubMed ID: 11357207
[TBL] [Abstract][Full Text] [Related]
27. Two doses of measles vaccine reduce measles dealths.
van den Ent M; Gupta SK; Hoekstra E
Indian Pediatr; 2009 Nov; 46(11):933-8. PubMed ID: 19955576
[TBL] [Abstract][Full Text] [Related]
28. Measles epidemiology and elimination strategies in Turkey.
Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
[TBL] [Abstract][Full Text] [Related]
29. Achieving measles control: lessons from the 2002-06 measles control strategy for Uganda.
Mbabazi WB; Nanyunja M; Makumbi I; Braka F; Baliraine FN; Kisakye A; Bwogi J; Mugyenyi P; Kabwongera E; Lewis RF
Health Policy Plan; 2009 Jul; 24(4):261-9. PubMed ID: 19282484
[TBL] [Abstract][Full Text] [Related]
30. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001.
Munyoro MN; Kufa E; Biellik R; Pazvakavambwa IE; Cairns KL
J Infect Dis; 2003 May; 187 Suppl 1():S91-6. PubMed ID: 12721898
[TBL] [Abstract][Full Text] [Related]
31. Integrating insecticide-treated bednets into a measles vaccination campaign achieves high, rapid and equitable coverage with direct and voucher-based methods.
Grabowsky M; Farrell N; Hawley W; Chimumbwa J; Hoyer S; Wolkon A; Selanikio J
Trop Med Int Health; 2005 Nov; 10(11):1151-60. PubMed ID: 16262740
[TBL] [Abstract][Full Text] [Related]
32. Future savings from measles eradication in industrialized countries.
Carabin H; Edmunds WJ
J Infect Dis; 2003 May; 187 Suppl 1():S29-35. PubMed ID: 12721889
[TBL] [Abstract][Full Text] [Related]
33. [The impact of immunization against measles on epidemiology of measles in Poland].
Janaszek W
Przegl Epidemiol; 1998; 52(4):413-25. PubMed ID: 10321085
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the mass measles vaccination campaign in Guangdong Province, China.
Peng ZQ; Chen WS; He Q; Peng GW; Wu CG; Xu N; Zhao ZJ; Shu J; Tan Q; Zheng HZ; Lin LF; Deng HH; Lin JY; Zhang YH
Int J Infect Dis; 2012 Feb; 16(2):e99-103. PubMed ID: 22119269
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of routine and campaign vaccination strategies in Ecuador.
Shepard DS; Robertson RL; Cameron CS; Saturno P; Pollack M; Manceau J; Martínez P; Meissner P; Perrone J
Bull World Health Organ; 1989; 67(6):649-62. PubMed ID: 2517411
[TBL] [Abstract][Full Text] [Related]
36. Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: an economic analysis.
Hammerschmidt T; Bisanz H; Wutzler P
Vaccine; 2007 Oct; 25(42):7307-12. PubMed ID: 17881097
[TBL] [Abstract][Full Text] [Related]
37. An economic analysis of the universal varicella vaccination program in the United States.
Zhou F; Ortega-Sanchez IR; Guris D; Shefer A; Lieu T; Seward JF
J Infect Dis; 2008 Mar; 197 Suppl 2():S156-64. PubMed ID: 18419391
[TBL] [Abstract][Full Text] [Related]
38. Impact of the 1996-1997 supplementary measles vaccination campaigns in South Africa.
Uzicanin A; Eggers R; Webb E; Harris B; Durrheim D; Ogunbanjo G; Isaacs V; Hawkridge A; Biellik R; Strebel P
Int J Epidemiol; 2002 Oct; 31(5):968-76. PubMed ID: 12435769
[TBL] [Abstract][Full Text] [Related]
39. Preplanned national measles vaccination campaign at the beginning of a measles outbreak--Sierra Leone, 2009-2010.
Sugerman DE; Fall A; Guigui MT; N'dolie M; Balogun T; Wurie A; Goodson JL
J Infect Dis; 2011 Jul; 204 Suppl 1():S260-9. PubMed ID: 21666171
[TBL] [Abstract][Full Text] [Related]
40. [Effectiveness, population-level effects, and heath economics of measles and rubella vaccination].
Wichmann O; Ultsch B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1260-9. PubMed ID: 23990088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
